BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 12738789)

  • 1. Bcl-xL mediates a survival mechanism independent of the phosphoinositide 3-kinase/Akt pathway in prostate cancer cells.
    Yang CC; Lin HP; Chen CS; Yang YT; Tseng PH; Rangnekar VM; Chen CS
    J Biol Chem; 2003 Jul; 278(28):25872-8. PubMed ID: 12738789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-survival function of Akt/protein kinase B in prostate cancer cells. Relationship with TRAIL resistance.
    Thakkar H; Chen X; Tyan F; Gim S; Robinson H; Lee C; Pandey SK; Nwokorie C; Onwudiwe N; Srivastava RK
    J Biol Chem; 2001 Oct; 276(42):38361-9. PubMed ID: 11461904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer.
    Chen X; Thakkar H; Tyan F; Gim S; Robinson H; Lee C; Pandey SK; Nwokorie C; Onwudiwe N; Srivastava RK
    Oncogene; 2001 Sep; 20(42):6073-83. PubMed ID: 11593415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C5b-9 terminal complement complex protects oligodendrocytes from death by regulating Bad through phosphatidylinositol 3-kinase/Akt pathway.
    Soane L; Cho HJ; Niculescu F; Rus H; Shin ML
    J Immunol; 2001 Aug; 167(4):2305-11. PubMed ID: 11490019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p38 MAPK mediates gamma-irradiation-induced endothelial cell apoptosis, and vascular endothelial growth factor protects endothelial cells through the phosphoinositide 3-kinase-Akt-Bcl-2 pathway.
    Kumar P; Miller AI; Polverini PJ
    J Biol Chem; 2004 Oct; 279(41):43352-60. PubMed ID: 15292252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria.
    Tsuruta F; Masuyama N; Gotoh Y
    J Biol Chem; 2002 Apr; 277(16):14040-7. PubMed ID: 11842081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different antiapoptotic pathways between wild-type and mutated FLT3: insights into therapeutic targets in leukemia.
    Minami Y; Yamamoto K; Kiyoi H; Ueda R; Saito H; Naoe T
    Blood; 2003 Oct; 102(8):2969-75. PubMed ID: 12842996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt.
    Woo JH; Kim YH; Choi YJ; Kim DG; Lee KS; Bae JH; Min DS; Chang JS; Jeong YJ; Lee YH; Park JW; Kwon TK
    Carcinogenesis; 2003 Jul; 24(7):1199-208. PubMed ID: 12807727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells.
    Pfeil K; Eder IE; Putz T; Ramoner R; Culig Z; Ueberall F; Bartsch G; Klocker H
    Prostate; 2004 Feb; 58(3):259-68. PubMed ID: 14743465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of PI 3-kinase, Akt and Bcl-2-related proteins in sustaining the survival of neurotrophic factor-independent adult sympathetic neurons.
    Orike N; Middleton G; Borthwick E; Buchman V; Cowen T; Davies AM
    J Cell Biol; 2001 Sep; 154(5):995-1005. PubMed ID: 11524433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.
    Martelli AM; Tazzari PL; Tabellini G; Bortul R; Billi AM; Manzoli L; Ruggeri A; Conte R; Cocco L
    Leukemia; 2003 Sep; 17(9):1794-805. PubMed ID: 12970779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy between phosphatidylinositol 3-kinase/Akt pathway and Bcl-xL in the control of apoptosis in adenocarcinoma cells of the lung.
    Qian J; Zou Y; Rahman JS; Lu B; Massion PP
    Mol Cancer Ther; 2009 Jan; 8(1):101-9. PubMed ID: 19139118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombopoietin regulates Bcl-xL gene expression through Stat5 and phosphatidylinositol 3-kinase activation pathways.
    Kirito K; Watanabe T; Sawada K; Endo H; Ozawa K; Komatsu N
    J Biol Chem; 2002 Mar; 277(10):8329-37. PubMed ID: 11756417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutively activated Akt-1 is vital for the survival of human monocyte-differentiated macrophages. Role of Mcl-1, independent of nuclear factor (NF)-kappaB, Bad, or caspase activation.
    Liu H; Perlman H; Pagliari LJ; Pope RM
    J Exp Med; 2001 Jul; 194(2):113-26. PubMed ID: 11457886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance.
    Campbell RA; Bhat-Nakshatri P; Patel NM; Constantinidou D; Ali S; Nakshatri H
    J Biol Chem; 2001 Mar; 276(13):9817-24. PubMed ID: 11139588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PI3-kinase-Akt pathway promotes mesangial cell survival and inhibits apoptosis in vitro via NF-kappa B and Bad.
    Shimamura H; Terada Y; Okado T; Tanaka H; Inoshita S; Sasaki S
    J Am Soc Nephrol; 2003 Jun; 14(6):1427-34. PubMed ID: 12761242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the phosphatidylinositol 3-kinase/Akt pathway sensitizes MDA-MB468 human breast cancer cells to cerulenin-induced apoptosis.
    Liu X; Shi Y; Giranda VL; Luo Y
    Mol Cancer Ther; 2006 Mar; 5(3):494-501. PubMed ID: 16546963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2.
    Hsu AL; Ching TT; Wang DS; Song X; Rangnekar VM; Chen CS
    J Biol Chem; 2000 Apr; 275(15):11397-403. PubMed ID: 10753955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitisation of HL60 human leukaemic cells to cytotoxic drug-induced apoptosis by inhibition of PI3-kinase survival signals.
    O'Gorman DM; McKenna SL; McGahon AJ; Knox KA; Cotter TG
    Leukemia; 2000 Apr; 14(4):602-11. PubMed ID: 10764145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells. Involvement of phosphatidylinositol 3-kinase/Akt pathway.
    Lin MT; Lee RC; Yang PC; Ho FM; Kuo ML
    J Biol Chem; 2001 Dec; 276(52):48997-9002. PubMed ID: 11585835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.